This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
3 Reasons Growth Investors Will Love HCA (HCA)
by Zacks Equity Research
HCA (HCA) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Is HCA Holdings (HCA) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Will Walgreens Boots' (WBA) Retail Arm be Dull in Q2 Earnings?
by Zacks Equity Research
Walgreens Boots' (WBA) Retail Pharmacy International sales are likely to have remained dull in Q2 on difficult global market scenario.
Here's Why You Should Retain Mednax (MD) in Your Portfolio
by Zacks Equity Research
Riding high on strategic initiatives and telehealth medicine, MEDNAX (MD) holds potential to reap benefits for investors.
Acadia Healthcare (ACHC) Gets Rating Upgrade Post U.K. Unit Sale
by Zacks Equity Research
Acadia Healthcare's (ACHC) numerous ratings get upgraded by Moody's after the divestment of its U.K. operations.
Encompass Health (EHC) Set to Boost South Carolina Footprint
by Zacks Equity Research
Encompass Health (EHC) introduced plans to construct a hospital in South Carolina for offering enhanced rehabilitative care across the state.
Mednax (MD) Ties Up With NightLight to Offer Better Pediatric Care
by Zacks Equity Research
Mednax (MD) collaborates with NighLight with an aim to offer enhanced pediatric care in Texas.
Molina Healthcare (MOH) Up 86% in a Year: More Room to Run?
by Zacks Equity Research
Molina Healthcare (MOH) is well-poised to gain from a robust Medicare and Medicaid business, and numerous buyouts for boosting its service offerings.
5 ROE Picks to Profit on Leisure Travel Uptrend Optimism
by Supriyo Bose
CDW Corporation (CDW), HCA Healthcare (HCA), Virtu Financial (VIRT), Polaris (PII) and D.R. Horton (DHI) are some of top ROE stocks to profit as markets trade near all-time high on renewed optimism of faster economic recovery.
If You Invested $1000 in HCA Holdings a Decade Ago, This is How Much It'd Be Worth Now
by Zacks Equity Research
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Zacks.com featured highlights include: HCA Healthcare, East West Bancorp, CDW Corp, T. Rowe Price Group and KLA Corp
by Zacks Equity Research
Zacks.com featured highlights include: HCA Healthcare, East West Bancorp, CDW Corp, T. Rowe Price Group and KLA Corp
Apollo Medical Holdings, Inc. (AMEH) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
Apollo Medical Holdings, Inc. (AMEH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
5 GARP Stocks for a Winning Portfolio
by Shilpa Mete
Growth at a reasonable price or GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount.
Why Should You Hold HCA Healthcare (HCA) in Your Portfolio?
by Zacks Equity Research
Riding high on a solid 2021 outlook and strategic measures, HCA Healthcare (HCA) has enough potential to reap benefits for investors.
Why Should You Add Community Health (CYH) to Your Portfolio?
by Zacks Equity Research
Riding high on telehealth services and cost-cutting measures, Community Health (CYH) holds potential to reap benefits for investors.
Tenet Healthcare (THC) Unit Extends Services to NorthShore
by Zacks Equity Research
Tenet Healthcare's (THC) unit Conifer extends alliance with NorthShore till 2024 with an aim to offer enhanced revenue cycle services to NorthShore.
3 Reasons Growth Investors Will Love HCA (HCA)
by Zacks Equity Research
HCA (HCA) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Should Value Investors Buy HCA Holdings (HCA) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Why Is HCA (HCA) Up 1.4% Since Last Earnings Report?
by Zacks Equity Research
HCA (HCA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why You Should Hold on to Universal Health (UHS) Now
by Zacks Equity Research
Riding high on its solid segments and an impressive top line, Universal Health (UHS) holds enough potential to reap benefits for investors.
Universal Health (UHS) Q4 Earnings Beat, Revenues Up Y/Y
by Zacks Equity Research
Universal Health's (UHS) fourth-quarter results reflect improved revenues across the company's segments, partly offset by elevated costs.
Select Medical (SEM) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Select Medical's (SEM) Q4 results reflect solid performances by its Critical Illness Recovery and Rehabilitation Hospital segments.
Acadia Healthcare (ACHC) Q4 Earnings Top Estimates, Rise Y/Y
by Zacks Equity Research
Acadia Healthcare's (ACHC) Q4 results reflect progress in its U.S business, which gained from solid volumes, and its solid cost-management policy.
Universal Health (UHS) to Report Q4 Results: What to Expect?
by Zacks Equity Research
Universal Health's (UHS) fourth-quarter results are likely to reflect gain from better revenues.
MEDNAX's (MD) Q4 Earnings Fall Shy of Estimates, Tumble Y/Y
by Zacks Equity Research
MEDNAX's (MD) fourth-quarter results reflect muted revenues caused by the COVID-19 pandemic.